What is Glide Pharmaceutical Technologies?
Glide Pharmaceutical Technologies is a company dedicated to offering comprehensive product engineering services, with a pronounced specialization in embedded hardware, software development, and Internet of Things (IoT) solutions. The firm's core mission revolves around the efficient transformation of innovative client concepts into tangible, market-ready products. Serving a broad spectrum of industries, including SaaS, Virtual Reality (VR), and tech accessories, Glide Pharmaceutical Technologies positions itself as a key partner for businesses aiming to drive innovation and enhance their product portfolios through advanced technological solutions.
How much funding has Glide Pharmaceutical Technologies raised?
Glide Pharmaceutical Technologies has raised a total of $4M across 1 funding round:
Private Equity
$4M
Private Equity (2017): $4M with participation from Oxford Capital Partners, Invesco, and Hygea VCT
Key Investors in Glide Pharmaceutical Technologies
Oxford Capital Partners
Oxford Capital Partners, established in 1999, is an investment manager based in Oxford, UK, providing growth capital to smaller companies across various industries to support their expansion.
Invesco
Invesco Ltd. is a global investment management firm offering a wide range of investment services to institutional and retail clients, managing diverse portfolios across equity, fixed income, and alternative markets.
Hygea VCT
Hygea VCT, now operating as Seneca Growth Capital VCT Plc, specializes in venture capital investments, focusing on funding and supporting growing businesses within the UK market.
What's next for Glide Pharmaceutical Technologies?
With the recent major strategic investment, Glide Pharmaceutical Technologies is poised for accelerated growth and innovation. The substantial capital infusion, part of its $4M in total funding, suggests a move towards scaling operations, expanding market reach, and potentially investing in research and development for next-generation pharmaceutical technologies. This backing from prominent investors indicates a strong belief in the company's business model and its capacity to capture a larger share of the evolving pharmaceutical technology market. Future developments are likely to focus on solidifying its position as a leader in product engineering for the health sciences sector.
See full Glide Pharmaceutical Technologies company page
